GeoVax Labs, Inc.
GOVX
$0.9145
-$0.0955-9.46%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 22.04% | 6.55% | -9.38% | 56.98% | 65.59% |
| Gross Profit | -8.18% | 33.60% | 15.75% | -56.98% | -65.59% |
| SG&A Expenses | 9.64% | -24.86% | -25.57% | 0.41% | -10.04% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 19.69% | 0.52% | -13.20% | 37.76% | 42.81% |
| Operating Income | -8.46% | 31.92% | 18.07% | -37.76% | -42.81% |
| Income Before Tax | -8.83% | 30.84% | 14.57% | -44.88% | -41.02% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -8.83% | 30.84% | 14.57% | -44.88% | -41.02% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -8.83% | 30.84% | 14.57% | -44.88% | -41.02% |
| EBIT | -8.46% | 31.92% | 18.07% | -37.76% | -42.81% |
| EBITDA | -8.49% | 32.14% | 18.23% | -37.86% | -42.77% |
| EPS Basic | 77.65% | 80.89% | 47.43% | -7.48% | -25.50% |
| Normalized Basic EPS | 77.65% | 80.89% | 47.43% | -7.47% | -25.50% |
| EPS Diluted | 77.65% | 80.89% | 47.43% | -7.48% | -25.50% |
| Normalized Diluted EPS | 77.65% | 80.89% | 47.43% | -7.47% | -25.50% |
| Average Basic Shares Outstanding | 386.96% | 261.93% | 62.51% | 34.81% | 12.37% |
| Average Diluted Shares Outstanding | 386.96% | 261.93% | 62.51% | 34.81% | 12.37% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |